oxazolidin-2-one has been researched along with 3,4-dihydroxyphenylglycol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berlin, I; Hergueta, T; Payan, C; Puech, AJ; Robin, L; Thiede, HM; Zimmer, R | 1 |
| Birk, KL; Cohen, AF; De Puy, ME; De Smet, M; Fisher, AL; Goldberg, MR; Musson, DG; Sterrett, A; Van Gerven, JM; Van Haarst, AD | 1 |
2 trial(s) available for oxazolidin-2-one and 3,4-dihydroxyphenylglycol
| Article | Year |
|---|---|
Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.
Topics: Adult; Benzamides; Double-Blind Method; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Psychometrics; Psychophysiology | 1990 |
The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers.
Topics: Adult; Area Under Curve; Benzamides; Biotransformation; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 1999 |